InsidersTradesSigma
Follow the 乐普医疗 stock price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 乐普医疗 has recorded 2 insider filings. Market capitalisation: €24.1bn. The latest transaction was disclosed on 24 August 2026 (Purchase). Among the most active insiders: 蒲忠杰. The full history is openly available.
Analysts rate 乐普医疗 Strong Buy (bullish), based on 4 analysts. Average price target: CN¥19.39.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
乐普医疗是一家专注于医疗保健和制药领域的公司，为医疗诊断和治疗提供创新解决方案。该公司在XSHE市场上市。